Effects of Synthetic Toll-Like Receptor 9 Ligand Molecules on Pulpal Immunomodulatory Response and Repair after Injuries
- ,
- Tomohiko Yamazaki,
- Hayato Ohshima(corresponding author)
- ,
- National Institute of Material Sciences (NIMS),
- Niigata University Graduate School of Medical and Dental Sciences
Research Output:
Contribution to journal
Article
Research
Peer-reviewOpen access
Publication Information
Output type
Research Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
EnglishArticle number
931Journal (Volume, Issue Number)
Biomolecules (Volume 14, Issue 8)Publication milestones
- Published - 08/2024
Publication status
Published - 08/2024
Publication IDs
- Scopus: 85202524099
Abstract
<p>Synthetic oligodeoxynucleotides (ODNs) containing unmethylated cytosine–phosphate–guanine (CpG) motifs (CpG-ODNs) are ligand molecules for Toll-like receptor 9 (TLR9), which is expressed by odontoblasts in vitro and dental pulp cells. This study determined the effects of CpG-ODNs on pulpal immunomodulatory response and repair following injury. Briefly, the upper right first molars of three-week-old mice were extracted, immersed in Type A (D35) or B (K3) CpG-ODN solutions (0.1 or 0.8 mM) for 30 min, and then replanted. Pulpal healing and immunomodulatory activity were assessed by hematoxylin–eosin and AZAN staining, as well as immunohistochemistry. One week following the operation, inflammatory reactions occurred in all of the experimental groups; however, re-revascularization and newly formed hard tissue deposition were observed in the pulp chamber of all groups at week 2. A positive trend in the expression of immune cell markers was observed toward the CpG-ODN groups at 0.1 mM. Our data suggest that synthetic CpG-ODN solutions at low concentrations may evoke a long-lasting macrophage–TLR9-mediated pro-inflammatory, rather than anti-inflammatory, response in the dental pulp to modulate the repair process and hard tissue formation. Further studies are needed to determine the effects of current immunomodulatory agents in vitro and in vivo and develop treatment strategies for dental tissue regeneration.</p>
Access to documents
Publication metrics
Metrics
PlumX, opens in new tab
Mentions
1
Citation count
6
Captures
9
